

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | formation of translation preinitiation complex (GO:0001731) | 5.12118667 |
| 2 | ribosome assembly (GO:0042255) | 5.10031340 |
| 3 | purine nucleobase biosynthetic process (GO:0009113) | 4.95761698 |
| 4 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.81936317 |
| 5 | nucleobase biosynthetic process (GO:0046112) | 4.79875343 |
| 6 | mitotic metaphase plate congression (GO:0007080) | 4.61417544 |
| 7 | fatty acid elongation (GO:0030497) | 4.59338739 |
| 8 | ribosome biogenesis (GO:0042254) | 4.44916823 |
| 9 | purine nucleotide salvage (GO:0032261) | 4.42734278 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 4.36468736 |
| 11 | regulation of cholesterol esterification (GO:0010872) | 4.28414937 |
| 12 | DNA replication checkpoint (GO:0000076) | 4.12810184 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.09001991 |
| 14 | rRNA modification (GO:0000154) | 4.00819690 |
| 15 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.94779112 |
| 16 | regulation of spindle organization (GO:0090224) | 3.87373796 |
| 17 | heart process (GO:0003015) | 3.86527307 |
| 18 | heart contraction (GO:0060047) | 3.86527307 |
| 19 | folic acid metabolic process (GO:0046655) | 3.81556158 |
| 20 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.76073405 |
| 21 | regulation of gene silencing by miRNA (GO:0060964) | 3.76073405 |
| 22 | regulation of gene silencing by RNA (GO:0060966) | 3.76073405 |
| 23 | mitotic nuclear envelope disassembly (GO:0007077) | 3.74058334 |
| 24 | nucleotide salvage (GO:0043173) | 3.72436981 |
| 25 | phospholipid efflux (GO:0033700) | 3.69610549 |
| 26 | DNA replication initiation (GO:0006270) | 3.69389115 |
| 27 | iron-sulfur cluster assembly (GO:0016226) | 3.68877841 |
| 28 | metallo-sulfur cluster assembly (GO:0031163) | 3.68877841 |
| 29 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.67264621 |
| 30 | metaphase plate congression (GO:0051310) | 3.64711505 |
| 31 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.61634752 |
| 32 | ribosomal large subunit biogenesis (GO:0042273) | 3.61365922 |
| 33 | protein localization to kinetochore (GO:0034501) | 3.59649200 |
| 34 | DNA deamination (GO:0045006) | 3.59064599 |
| 35 | protein K6-linked ubiquitination (GO:0085020) | 3.57638895 |
| 36 | rRNA processing (GO:0006364) | 3.57013741 |
| 37 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.54728673 |
| 38 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.53000710 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.50867644 |
| 40 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.48437847 |
| 41 | proteasome assembly (GO:0043248) | 3.45901114 |
| 42 | membrane disassembly (GO:0030397) | 3.44767405 |
| 43 | nuclear envelope disassembly (GO:0051081) | 3.44767405 |
| 44 | extracellular fibril organization (GO:0043206) | 3.44765702 |
| 45 | rRNA metabolic process (GO:0016072) | 3.44047546 |
| 46 | peptidyl-histidine modification (GO:0018202) | 3.44020872 |
| 47 | ribosomal small subunit biogenesis (GO:0042274) | 3.41186324 |
| 48 | translational initiation (GO:0006413) | 3.40734303 |
| 49 | regulation of mitotic spindle organization (GO:0060236) | 3.39177656 |
| 50 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.38543862 |
| 51 | IMP biosynthetic process (GO:0006188) | 3.35927318 |
| 52 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.35145743 |
| 53 | deoxyribose phosphate catabolic process (GO:0046386) | 3.29564047 |
| 54 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.27380245 |
| 55 | spliceosomal snRNP assembly (GO:0000387) | 3.27218696 |
| 56 | termination of RNA polymerase I transcription (GO:0006363) | 3.27183525 |
| 57 | positive regulation of chromosome segregation (GO:0051984) | 3.26860460 |
| 58 | viral transcription (GO:0019083) | 3.25533482 |
| 59 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.25533264 |
| 60 | maturation of 5.8S rRNA (GO:0000460) | 3.25155341 |
| 61 | nuclear pore organization (GO:0006999) | 3.24962520 |
| 62 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.24382182 |
| 63 | protein deneddylation (GO:0000338) | 3.24208129 |
| 64 | translational termination (GO:0006415) | 3.23030160 |
| 65 | cullin deneddylation (GO:0010388) | 3.22540215 |
| 66 | pseudouridine synthesis (GO:0001522) | 3.22435037 |
| 67 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.21876561 |
| 68 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.20249795 |
| 69 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.20249795 |
| 70 | DNA strand elongation (GO:0022616) | 3.18599547 |
| 71 | transcription from RNA polymerase I promoter (GO:0006360) | 3.18370270 |
| 72 | deoxyribonucleotide catabolic process (GO:0009264) | 3.17657180 |
| 73 | regulation of translation in response to stress (GO:0043555) | 3.15552080 |
| 74 | neutrophil activation involved in immune response (GO:0002283) | 3.14778446 |
| 75 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.13842080 |
| 76 | mannose metabolic process (GO:0006013) | 3.13456387 |
| 77 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.12883011 |
| 78 | branched-chain amino acid catabolic process (GO:0009083) | 3.11734194 |
| 79 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.11105975 |
| 80 | rRNA methylation (GO:0031167) | 3.09743974 |
| 81 | fibril organization (GO:0097435) | 3.08703286 |
| 82 | mature B cell differentiation involved in immune response (GO:0002313) | 3.08308361 |
| 83 | translational elongation (GO:0006414) | 3.05705193 |
| 84 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.04526638 |
| 85 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.04364403 |
| 86 | termination of RNA polymerase III transcription (GO:0006386) | 3.02734222 |
| 87 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.02734222 |
| 88 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.02335895 |
| 89 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.02101433 |
| 90 | establishment of chromosome localization (GO:0051303) | 3.00926594 |
| 91 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.97963327 |
| 92 | membrane raft organization (GO:0031579) | 2.97474038 |
| 93 | protein localization to chromosome, centromeric region (GO:0071459) | 2.97438207 |
| 94 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.96805581 |
| 95 | ribosomal small subunit assembly (GO:0000028) | 2.96236854 |
| 96 | transcription from mitochondrial promoter (GO:0006390) | 2.96119671 |
| 97 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.95404952 |
| 98 | negative regulation of ligase activity (GO:0051352) | 2.94134742 |
| 99 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.94134742 |
| 100 | blastocyst development (GO:0001824) | 2.93769174 |
| 101 | folic acid transport (GO:0015884) | 2.90373182 |
| 102 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.89329365 |
| 103 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.88917801 |
| 104 | acyl-CoA biosynthetic process (GO:0071616) | 2.87794858 |
| 105 | thioester biosynthetic process (GO:0035384) | 2.87794858 |
| 106 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.87711757 |
| 107 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.87033396 |
| 108 | amyloid precursor protein catabolic process (GO:0042987) | 2.85461675 |
| 109 | negative regulation of chromosome segregation (GO:0051985) | 2.84615745 |
| 110 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.83958207 |
| 111 | cell cycle G1/S phase transition (GO:0044843) | 2.83958207 |
| 112 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.83376520 |
| 113 | regulation of helicase activity (GO:0051095) | 2.82662963 |
| 114 | positive regulation of ligase activity (GO:0051351) | 2.82621042 |
| 115 | mannosylation (GO:0097502) | 2.82495519 |
| 116 | 7-methylguanosine mRNA capping (GO:0006370) | 2.79820150 |
| 117 | aggressive behavior (GO:0002118) | 2.78278814 |
| 118 | IMP metabolic process (GO:0046040) | 2.77960192 |
| 119 | nuclear envelope organization (GO:0006998) | 2.77495402 |
| 120 | regulation of centrosome cycle (GO:0046605) | 2.76679732 |
| 121 | mitotic sister chromatid segregation (GO:0000070) | 2.75975784 |
| 122 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.75893717 |
| 123 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.75699817 |
| 124 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.74698514 |
| 125 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.74698514 |
| 126 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.74509915 |
| 127 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.73968095 |
| 128 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.73968095 |
| 129 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.73968095 |
| 130 | protein kinase C signaling (GO:0070528) | 2.73386974 |
| 131 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.73186333 |
| 132 | purine-containing compound salvage (GO:0043101) | 2.73178226 |
| 133 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.73092344 |
| 134 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.73092344 |
| 135 | telomere maintenance via telomere lengthening (GO:0010833) | 2.72969205 |
| 136 | spindle checkpoint (GO:0031577) | 2.72458651 |
| 137 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.72256919 |
| 138 | negative regulation of sister chromatid segregation (GO:0033046) | 2.72256919 |
| 139 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.72256919 |
| 140 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.72256919 |
| 141 | T cell migration (GO:0072678) | 2.70923508 |
| 142 | alpha-linolenic acid metabolic process (GO:0036109) | 2.68184854 |
| 143 | aerobic respiration (GO:0009060) | 2.68027634 |
| 144 | galactose catabolic process (GO:0019388) | 2.66481042 |
| 145 | plasma lipoprotein particle clearance (GO:0034381) | 2.66076097 |
| 146 | glutathione derivative biosynthetic process (GO:1901687) | 2.64619030 |
| 147 | glutathione derivative metabolic process (GO:1901685) | 2.64619030 |
| 148 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.62812737 |
| 149 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.62321179 |
| 150 | nucleoside salvage (GO:0043174) | 2.62218587 |
| 151 | cell wall macromolecule catabolic process (GO:0016998) | 2.59950865 |
| 152 | hemoglobin metabolic process (GO:0020027) | 2.57292916 |
| 153 | lipopolysaccharide metabolic process (GO:0008653) | 2.56383468 |
| 154 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.55478946 |
| 155 | cholesterol catabolic process (GO:0006707) | 2.53741794 |
| 156 | sterol catabolic process (GO:0016127) | 2.53741794 |
| 157 | pinocytosis (GO:0006907) | 2.53002562 |
| 158 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.52754523 |
| 159 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.52754523 |
| 160 | hydrogen peroxide catabolic process (GO:0042744) | 2.50951824 |
| 161 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.50754909 |
| 162 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.50503860 |
| 163 | branched-chain amino acid metabolic process (GO:0009081) | 2.50267042 |
| 164 | response to interferon-beta (GO:0035456) | 2.49175250 |
| 165 | positive regulation of cholesterol efflux (GO:0010875) | 2.48023121 |
| 166 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.47513754 |
| 167 | response to gravity (GO:0009629) | 2.46988998 |
| 168 | valine metabolic process (GO:0006573) | 2.45989096 |
| 169 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.45439302 |
| 170 | negative T cell selection (GO:0043383) | 2.44212881 |
| 171 | estrogen biosynthetic process (GO:0006703) | 2.43845602 |
| 172 | deoxyribose phosphate metabolic process (GO:0019692) | 2.43333886 |
| 173 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.41752908 |
| 174 | GMP metabolic process (GO:0046037) | 2.40157119 |
| 175 | tricarboxylic acid cycle (GO:0006099) | 2.39785417 |
| 176 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.39002341 |
| 177 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.38054582 |
| 178 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.34180574 |
| 179 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.33685933 |
| 180 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.33685933 |
| 181 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.33474263 |
| 182 | vagina development (GO:0060068) | 2.33062813 |
| 183 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.32715173 |
| 184 | glyoxylate metabolic process (GO:0046487) | 2.32493709 |
| 185 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.32429154 |
| 186 | cellular metabolic compound salvage (GO:0043094) | 2.32308318 |
| 187 | positive thymic T cell selection (GO:0045059) | 2.31677641 |
| 188 | high-density lipoprotein particle remodeling (GO:0034375) | 2.31613175 |
| 189 | positive regulation of interleukin-17 production (GO:0032740) | 2.31453073 |
| 190 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.31416562 |
| 191 | regulation of mast cell degranulation (GO:0043304) | 2.31127098 |
| 192 | glutathione biosynthetic process (GO:0006750) | 2.31119769 |
| 193 | Golgi transport vesicle coating (GO:0048200) | 2.30954699 |
| 194 | COPI coating of Golgi vesicle (GO:0048205) | 2.30954699 |
| 195 | positive regulation of sterol transport (GO:0032373) | 2.30813321 |
| 196 | positive regulation of cholesterol transport (GO:0032376) | 2.30813321 |
| 197 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.30014552 |
| 198 | hyperosmotic salinity response (GO:0042538) | 2.29484387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.88531804 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.12083739 |
| 3 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.27137959 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.25027187 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.89374029 |
| 6 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.71825450 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.69387954 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.68180183 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.68075711 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.57609215 |
| 11 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.53658065 |
| 12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.53658065 |
| 13 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.53658065 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.53370774 |
| 15 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.52758592 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.52615366 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.47641586 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.45301657 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.39701459 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.38970138 |
| 21 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.28880027 |
| 22 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.25795801 |
| 23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.20159319 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18051706 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.13315099 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.11969780 |
| 27 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.11341767 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.10887238 |
| 29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.10265432 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05796299 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.02924513 |
| 32 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.00288268 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.99142846 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98694070 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94293763 |
| 36 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.93513380 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.92164095 |
| 38 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.89466089 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.88894727 |
| 40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.88288430 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.87112237 |
| 42 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86951209 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86367053 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86205389 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.84929955 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.79590175 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79236003 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.76870561 |
| 49 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.76343515 |
| 50 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.74067977 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.73699776 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73572454 |
| 53 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.71714067 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71107017 |
| 55 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.66616947 |
| 56 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.66584325 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66457066 |
| 58 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.65842895 |
| 59 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.65312590 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.63769440 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61895150 |
| 62 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.58064250 |
| 63 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53244753 |
| 64 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52196218 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.50842262 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50549692 |
| 67 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.49998447 |
| 68 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.48025672 |
| 69 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.46884810 |
| 70 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.45571152 |
| 71 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42455521 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.42158282 |
| 73 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.42129154 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41371066 |
| 75 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.41343661 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40587439 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.39681625 |
| 78 | MYC_22102868_ChIP-Seq_BL_Human | 1.39222801 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39034682 |
| 80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.36317220 |
| 81 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.35609771 |
| 82 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.34065764 |
| 83 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.33791862 |
| 84 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.31131692 |
| 85 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.31075203 |
| 86 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29803763 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29722786 |
| 88 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.29404126 |
| 89 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.29204298 |
| 90 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.28979107 |
| 91 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.28924518 |
| 92 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27707862 |
| 93 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27459892 |
| 94 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.27327200 |
| 95 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26633052 |
| 96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.26511053 |
| 97 | MAF_26560356_Chip-Seq_TH1_Human | 1.26438067 |
| 98 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.25469654 |
| 99 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.25041946 |
| 100 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24911899 |
| 101 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.23228989 |
| 102 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23030805 |
| 103 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22841927 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22494241 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 1.22290282 |
| 106 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.22220412 |
| 107 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.22097239 |
| 108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21107407 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20594241 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20529800 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19807562 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19669711 |
| 113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19646894 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19489732 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19008058 |
| 116 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.18866617 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.18485250 |
| 118 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18234625 |
| 119 | MYB_26560356_Chip-Seq_TH2_Human | 1.17472246 |
| 120 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17154142 |
| 121 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16982598 |
| 122 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15168828 |
| 123 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13413794 |
| 124 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13057640 |
| 125 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.12682532 |
| 126 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.12260423 |
| 127 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12074761 |
| 128 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11875424 |
| 129 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11519071 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10819810 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10759625 |
| 132 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09985358 |
| 133 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09439753 |
| 134 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08681647 |
| 135 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08178937 |
| 136 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.08101158 |
| 137 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07866134 |
| 138 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07474170 |
| 139 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07077285 |
| 140 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05942002 |
| 141 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05695434 |
| 142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05460366 |
| 143 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05194945 |
| 144 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04592650 |
| 145 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04453267 |
| 146 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.04102128 |
| 147 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03763702 |
| 148 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03435998 |
| 149 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.03141663 |
| 150 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02942714 |
| 151 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02166391 |
| 152 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01566010 |
| 153 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01020172 |
| 154 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.00724968 |
| 155 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99842184 |
| 156 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.99535669 |
| 157 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.99535291 |
| 158 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.99457661 |
| 159 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99197377 |
| 160 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98261221 |
| 161 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98159826 |
| 162 | P68_20966046_ChIP-Seq_HELA_Human | 0.97992071 |
| 163 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.96358151 |
| 164 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.96113669 |
| 165 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.94699296 |
| 166 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.92682429 |
| 167 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91392419 |
| 168 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91280879 |
| 169 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91151172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.83933825 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.58791460 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 4.22326261 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.93840028 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.53309162 |
| 6 | MP0003077_abnormal_cell_cycle | 3.30690178 |
| 7 | MP0008057_abnormal_DNA_replication | 2.89749420 |
| 8 | MP0003436_decreased_susceptibility_to | 2.79739478 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.48789954 |
| 10 | MP0002736_abnormal_nociception_after | 2.41420318 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.38350005 |
| 12 | MP0003718_maternal_effect | 2.36655508 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.33822109 |
| 14 | MP0008058_abnormal_DNA_repair | 2.29583220 |
| 15 | MP0001730_embryonic_growth_arrest | 2.29258409 |
| 16 | MP0005670_abnormal_white_adipose | 2.19308466 |
| 17 | MP0008932_abnormal_embryonic_tissue | 2.18502666 |
| 18 | MP0003786_premature_aging | 2.11052218 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.08310681 |
| 20 | MP0000350_abnormal_cell_proliferation | 2.05347638 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.96922861 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.86248881 |
| 23 | MP0005380_embryogenesis_phenotype | 1.86182227 |
| 24 | MP0001672_abnormal_embryogenesis/_devel | 1.86182227 |
| 25 | MP0008004_abnormal_stomach_pH | 1.84831104 |
| 26 | MP0003011_delayed_dark_adaptation | 1.83802521 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.83242571 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.82959878 |
| 29 | MP0006054_spinal_hemorrhage | 1.77147092 |
| 30 | MP0006082_CNS_inflammation | 1.75418873 |
| 31 | MP0010030_abnormal_orbit_morphology | 1.73993323 |
| 32 | MP0001697_abnormal_embryo_size | 1.73173122 |
| 33 | MP0003123_paternal_imprinting | 1.69296872 |
| 34 | MP0002419_abnormal_innate_immunity | 1.68954481 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.66396059 |
| 36 | MP0003984_embryonic_growth_retardation | 1.66229269 |
| 37 | MP0002086_abnormal_extraembryonic_tissu | 1.64156851 |
| 38 | MP0002405_respiratory_system_inflammati | 1.63975503 |
| 39 | MP0002088_abnormal_embryonic_growth/wei | 1.63331300 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.62347150 |
| 41 | MP0002254_reproductive_system_inflammat | 1.59690335 |
| 42 | MP0010307_abnormal_tumor_latency | 1.57598276 |
| 43 | MP0009785_altered_susceptibility_to | 1.57460012 |
| 44 | MP0002085_abnormal_embryonic_tissue | 1.57415485 |
| 45 | MP0003724_increased_susceptibility_to | 1.56738622 |
| 46 | MP0005023_abnormal_wound_healing | 1.56735086 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.56228984 |
| 48 | MP0003279_aneurysm | 1.54072233 |
| 49 | MP0001764_abnormal_homeostasis | 1.52549025 |
| 50 | MP0002084_abnormal_developmental_patter | 1.52534835 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.52419170 |
| 52 | MP0002080_prenatal_lethality | 1.50035948 |
| 53 | MP0003941_abnormal_skin_development | 1.49227153 |
| 54 | MP0001968_abnormal_touch/_nociception | 1.42995436 |
| 55 | MP0000343_altered_response_to | 1.39742710 |
| 56 | MP0003950_abnormal_plasma_membrane | 1.39666845 |
| 57 | MP0002723_abnormal_immune_serum | 1.39070776 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.37856472 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.37355928 |
| 60 | MP0002933_joint_inflammation | 1.31299084 |
| 61 | MP0001819_abnormal_immune_cell | 1.31078207 |
| 62 | MP0003119_abnormal_digestive_system | 1.30946057 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.30695016 |
| 64 | MP0002452_abnormal_antigen_presenting | 1.29191934 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 1.28243832 |
| 66 | MP0003567_abnormal_fetal_cardiomyocyte | 1.25709963 |
| 67 | MP0005666_abnormal_adipose_tissue | 1.24048376 |
| 68 | MP0005025_abnormal_response_to | 1.22394066 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.20657176 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.19801622 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.19801622 |
| 72 | MP0004133_heterotaxia | 1.15938441 |
| 73 | MP0001873_stomach_inflammation | 1.15131441 |
| 74 | MP0000749_muscle_degeneration | 1.14334101 |
| 75 | MP0001849_ear_inflammation | 1.13955206 |
| 76 | MP0000313_abnormal_cell_death | 1.13684262 |
| 77 | MP0009384_cardiac_valve_regurgitation | 1.13538907 |
| 78 | MP0000767_abnormal_smooth_muscle | 1.13210147 |
| 79 | MP0003186_abnormal_redox_activity | 1.12794094 |
| 80 | MP0004197_abnormal_fetal_growth/weight/ | 1.12511091 |
| 81 | MP0009840_abnormal_foam_cell | 1.11057207 |
| 82 | MP0001293_anophthalmia | 1.09827838 |
| 83 | MP0009697_abnormal_copulation | 1.09771743 |
| 84 | MP0004883_abnormal_blood_vessel | 1.09561133 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 1.09487662 |
| 86 | MP0009278_abnormal_bone_marrow | 1.08333370 |
| 87 | MP0000750_abnormal_muscle_regeneration | 1.07862202 |
| 88 | MP0008877_abnormal_DNA_methylation | 1.07170751 |
| 89 | MP0001800_abnormal_humoral_immune | 1.04430534 |
| 90 | MP0002295_abnormal_pulmonary_circulatio | 1.03949813 |
| 91 | MP0008469_abnormal_protein_level | 1.03372537 |
| 92 | MP0000858_altered_metastatic_potential | 1.02884087 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 1.02737283 |
| 94 | MP0000490_abnormal_crypts_of | 1.02683361 |
| 95 | MP0005395_other_phenotype | 1.02550122 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 1.00804105 |
| 97 | MP0003878_abnormal_ear_physiology | 1.00804105 |
| 98 | MP0003075_altered_response_to | 1.00467714 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.98731127 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.98382429 |
| 101 | MP0000716_abnormal_immune_system | 0.98112763 |
| 102 | MP0003763_abnormal_thymus_physiology | 0.97923690 |
| 103 | MP0005390_skeleton_phenotype | 0.97645848 |
| 104 | MP0005367_renal/urinary_system_phenotyp | 0.97316531 |
| 105 | MP0000516_abnormal_urinary_system | 0.97316531 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.97268232 |
| 107 | MP0004947_skin_inflammation | 0.96411697 |
| 108 | MP0008260_abnormal_autophagy | 0.96215255 |
| 109 | MP0009764_decreased_sensitivity_to | 0.94796199 |
| 110 | MP0003315_abnormal_perineum_morphology | 0.94317469 |
| 111 | MP0000358_abnormal_cell_content/ | 0.92802253 |
| 112 | MP0000751_myopathy | 0.92643127 |
| 113 | MP0001853_heart_inflammation | 0.92616414 |
| 114 | MP0005451_abnormal_body_composition | 0.92107046 |
| 115 | MP0001851_eye_inflammation | 0.91688827 |
| 116 | MP0002132_abnormal_respiratory_system | 0.91497737 |
| 117 | MP0003890_abnormal_embryonic-extraembry | 0.91109934 |
| 118 | MP0002796_impaired_skin_barrier | 0.91015613 |
| 119 | MP0005076_abnormal_cell_differentiation | 0.90545668 |
| 120 | MP0004272_abnormal_basement_membrane | 0.89870997 |
| 121 | MP0002111_abnormal_tail_morphology | 0.87297662 |
| 122 | MP0001542_abnormal_bone_strength | 0.87202101 |
| 123 | MP0002722_abnormal_immune_system | 0.85450953 |
| 124 | MP0008873_increased_physiological_sensi | 0.84065124 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84005949 |
| 126 | MP0005621_abnormal_cell_physiology | 0.83889925 |
| 127 | MP0002972_abnormal_cardiac_muscle | 0.82609855 |
| 128 | MP0005330_cardiomyopathy | 0.82475631 |
| 129 | MP0000703_abnormal_thymus_morphology | 0.82208893 |
| 130 | MP0001835_abnormal_antigen_presentation | 0.81581978 |
| 131 | MP0000627_abnormal_mammary_gland | 0.80949240 |
| 132 | MP0004084_abnormal_cardiac_muscle | 0.80474541 |
| 133 | MP0001243_abnormal_dermal_layer | 0.79362079 |
| 134 | MP0003448_altered_tumor_morphology | 0.79360231 |
| 135 | MP0002429_abnormal_blood_cell | 0.78503376 |
| 136 | MP0005164_abnormal_response_to | 0.77943126 |
| 137 | MP0002210_abnormal_sex_determination | 0.77694027 |
| 138 | MP0005647_abnormal_sex_gland | 0.77339248 |
| 139 | MP0005464_abnormal_platelet_physiology | 0.77247177 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.77057168 |
| 141 | MP0005384_cellular_phenotype | 0.76145520 |
| 142 | MP0009643_abnormal_urine_homeostasis | 0.76088016 |
| 143 | MP0005501_abnormal_skin_physiology | 0.75131829 |
| 144 | MP0000428_abnormal_craniofacial_morphol | 0.74252195 |
| 145 | MP0001661_extended_life_span | 0.74121292 |
| 146 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.73715610 |
| 147 | MP0000689_abnormal_spleen_morphology | 0.73092053 |
| 148 | MP0005165_increased_susceptibility_to | 0.73051016 |
| 149 | MP0005671_abnormal_response_to | 0.72858307 |
| 150 | MP0010155_abnormal_intestine_physiology | 0.72619453 |
| 151 | MP0001881_abnormal_mammary_gland | 0.72287916 |
| 152 | MP0004808_abnormal_hematopoietic_stem | 0.71362717 |
| 153 | MP0000733_abnormal_muscle_development | 0.71104931 |
| 154 | MP0001145_abnormal_male_reproductive | 0.70805091 |
| 155 | MP0002269_muscular_atrophy | 0.70698793 |
| 156 | MP0001790_abnormal_immune_system | 0.70612400 |
| 157 | MP0005387_immune_system_phenotype | 0.70612400 |
| 158 | MP0005166_decreased_susceptibility_to | 0.70523664 |
| 159 | MP0002398_abnormal_bone_marrow | 0.69761904 |
| 160 | MP0003936_abnormal_reproductive_system | 0.69122496 |
| 161 | MP0004087_abnormal_muscle_fiber | 0.68051912 |
| 162 | MP0003136_yellow_coat_color | 0.67941509 |
| 163 | MP0001216_abnormal_epidermal_layer | 0.67575265 |
| 164 | MP0005389_reproductive_system_phenotype | 0.66436842 |
| 165 | MP0000685_abnormal_immune_system | 0.66276218 |
| 166 | MP0002136_abnormal_kidney_physiology | 0.66234681 |
| 167 | MP0002277_abnormal_respiratory_mucosa | 0.65921616 |
| 168 | MP0002098_abnormal_vibrissa_morphology | 0.65918621 |
| 169 | MP0005266_abnormal_metabolism | 0.65179980 |
| 170 | MP0002060_abnormal_skin_morphology | 0.64963109 |
| 171 | MP0003828_pulmonary_edema | 0.64474536 |
| 172 | MP0005275_abnormal_skin_tensile | 0.64039387 |
| 173 | MP0000477_abnormal_intestine_morphology | 0.63305718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 4.68404218 |
| 2 | Breast hypoplasia (HP:0003187) | 4.65414187 |
| 3 | Selective tooth agenesis (HP:0001592) | 4.44402365 |
| 4 | Mesangial abnormality (HP:0001966) | 3.86592757 |
| 5 | Carpal bone hypoplasia (HP:0001498) | 3.84865988 |
| 6 | Rough bone trabeculation (HP:0100670) | 3.79278843 |
| 7 | Agammaglobulinemia (HP:0004432) | 3.62123786 |
| 8 | Popliteal pterygium (HP:0009756) | 3.48487463 |
| 9 | Abnormality of placental membranes (HP:0011409) | 3.42596370 |
| 10 | Amniotic constriction ring (HP:0009775) | 3.42596370 |
| 11 | Prolonged neonatal jaundice (HP:0006579) | 3.40187171 |
| 12 | Patellar aplasia (HP:0006443) | 3.34772469 |
| 13 | Muscle fiber atrophy (HP:0100295) | 3.33846974 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.30874606 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.28703830 |
| 16 | Absent radius (HP:0003974) | 3.27842215 |
| 17 | Premature ovarian failure (HP:0008209) | 3.26303637 |
| 18 | Impulsivity (HP:0100710) | 3.24267998 |
| 19 | Type 2 muscle fiber atrophy (HP:0003554) | 3.16544988 |
| 20 | Trismus (HP:0000211) | 3.16451163 |
| 21 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.15785651 |
| 22 | Absent forearm bone (HP:0003953) | 3.14737188 |
| 23 | Aplasia involving forearm bones (HP:0009822) | 3.14737188 |
| 24 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.13553280 |
| 25 | Amyloidosis (HP:0011034) | 3.11646302 |
| 26 | Microretrognathia (HP:0000308) | 3.09913456 |
| 27 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.08444705 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.08444705 |
| 29 | Oral leukoplakia (HP:0002745) | 3.07935169 |
| 30 | Abnormality of the anterior horn cell (HP:0006802) | 3.06829450 |
| 31 | Degeneration of anterior horn cells (HP:0002398) | 3.06829450 |
| 32 | Abnormality of macrophages (HP:0004311) | 2.95511641 |
| 33 | Ependymoma (HP:0002888) | 2.94930649 |
| 34 | Multiple enchondromatosis (HP:0005701) | 2.94561329 |
| 35 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.91921579 |
| 36 | Petechiae (HP:0000967) | 2.91553483 |
| 37 | Cervical subluxation (HP:0003308) | 2.85046406 |
| 38 | Absent thumb (HP:0009777) | 2.80137846 |
| 39 | Dry hair (HP:0011359) | 2.73408517 |
| 40 | Abnormal trabecular bone morphology (HP:0100671) | 2.71959237 |
| 41 | Abnormality of the labia minora (HP:0012880) | 2.71315864 |
| 42 | Reticulocytopenia (HP:0001896) | 2.68405688 |
| 43 | Supernumerary spleens (HP:0009799) | 2.64516800 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 2.63050917 |
| 45 | Severe combined immunodeficiency (HP:0004430) | 2.62311422 |
| 46 | Spinal muscular atrophy (HP:0007269) | 2.62041004 |
| 47 | Stenosis of the external auditory canal (HP:0000402) | 2.61688318 |
| 48 | Colon cancer (HP:0003003) | 2.61403620 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.61221550 |
| 50 | Loss of speech (HP:0002371) | 2.60981168 |
| 51 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.59820721 |
| 52 | Stomatitis (HP:0010280) | 2.59013862 |
| 53 | Spastic paraparesis (HP:0002313) | 2.56822695 |
| 54 | Hypoplastic heart (HP:0001961) | 2.56772985 |
| 55 | Sparse eyelashes (HP:0000653) | 2.56340463 |
| 56 | Abnormality of the umbilical cord (HP:0010881) | 2.52416551 |
| 57 | Ureteral duplication (HP:0000073) | 2.50031755 |
| 58 | Easy fatigability (HP:0003388) | 2.44172277 |
| 59 | Short humerus (HP:0005792) | 2.43121368 |
| 60 | Type I transferrin isoform profile (HP:0003642) | 2.41890361 |
| 61 | Adactyly (HP:0009776) | 2.41151704 |
| 62 | Premature graying of hair (HP:0002216) | 2.37251927 |
| 63 | Hepatosplenomegaly (HP:0001433) | 2.35578663 |
| 64 | Meckel diverticulum (HP:0002245) | 2.35264512 |
| 65 | Aplasia of the musculature (HP:0100854) | 2.34164742 |
| 66 | Bulbar palsy (HP:0001283) | 2.33892928 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.33867784 |
| 68 | Joint stiffness (HP:0001387) | 2.33250790 |
| 69 | Increased IgM level (HP:0003496) | 2.32188798 |
| 70 | Secondary amenorrhea (HP:0000869) | 2.31687293 |
| 71 | Abnormality of the preputium (HP:0100587) | 2.31159816 |
| 72 | Weak cry (HP:0001612) | 2.31108226 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 2.30858969 |
| 74 | Cholecystitis (HP:0001082) | 2.30858969 |
| 75 | Acute encephalopathy (HP:0006846) | 2.30423004 |
| 76 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.29844407 |
| 77 | Squamous cell carcinoma (HP:0002860) | 2.27964266 |
| 78 | Abnormality of the ileum (HP:0001549) | 2.27950690 |
| 79 | Shawl scrotum (HP:0000049) | 2.27173881 |
| 80 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.26864158 |
| 81 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.26573811 |
| 82 | Fused cervical vertebrae (HP:0002949) | 2.25567165 |
| 83 | Abnormal number of incisors (HP:0011064) | 2.25467130 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.24412829 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22502692 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22502692 |
| 87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22502692 |
| 88 | Neoplasm of the pancreas (HP:0002894) | 2.21254751 |
| 89 | Neurodegeneration (HP:0002180) | 2.20278446 |
| 90 | Acute necrotizing encephalopathy (HP:0006965) | 2.19304953 |
| 91 | Glossoptosis (HP:0000162) | 2.18913726 |
| 92 | Cellular immunodeficiency (HP:0005374) | 2.18181841 |
| 93 | Combined immunodeficiency (HP:0005387) | 2.17620548 |
| 94 | Mitochondrial inheritance (HP:0001427) | 2.16340184 |
| 95 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.16279536 |
| 96 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.16279536 |
| 97 | Abnormal protein glycosylation (HP:0012346) | 2.16279536 |
| 98 | Abnormal glycosylation (HP:0012345) | 2.16279536 |
| 99 | Absent hand (HP:0004050) | 2.15815949 |
| 100 | Atresia of the external auditory canal (HP:0000413) | 2.15654548 |
| 101 | Rhabdomyolysis (HP:0003201) | 2.15634665 |
| 102 | Abnormal number of erythroid precursors (HP:0012131) | 2.15298256 |
| 103 | Hyperglycinuria (HP:0003108) | 2.14938061 |
| 104 | Gowers sign (HP:0003391) | 2.14475853 |
| 105 | B lymphocytopenia (HP:0010976) | 2.14060730 |
| 106 | Basal cell carcinoma (HP:0002671) | 2.11735394 |
| 107 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.11580953 |
| 108 | Progressive muscle weakness (HP:0003323) | 2.10665080 |
| 109 | Hyperglycinemia (HP:0002154) | 2.09828553 |
| 110 | Macrocytic anemia (HP:0001972) | 2.08953150 |
| 111 | Renal Fanconi syndrome (HP:0001994) | 2.08943476 |
| 112 | Cleft eyelid (HP:0000625) | 2.07893128 |
| 113 | Pustule (HP:0200039) | 2.07741739 |
| 114 | Muscle fibrillation (HP:0010546) | 2.07107950 |
| 115 | Horseshoe kidney (HP:0000085) | 2.07027638 |
| 116 | Rhabdomyosarcoma (HP:0002859) | 2.06571411 |
| 117 | Rib fusion (HP:0000902) | 2.06378253 |
| 118 | Breast aplasia (HP:0100783) | 2.05876995 |
| 119 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.05348828 |
| 120 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.05348828 |
| 121 | Single umbilical artery (HP:0001195) | 2.05348828 |
| 122 | Bone marrow hypocellularity (HP:0005528) | 2.05342038 |
| 123 | Mucopolysacchariduria (HP:0008155) | 2.04716780 |
| 124 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04716780 |
| 125 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.03388713 |
| 126 | Tracheoesophageal fistula (HP:0002575) | 2.03040734 |
| 127 | Death in infancy (HP:0001522) | 2.01874144 |
| 128 | Nausea (HP:0002018) | 2.00544118 |
| 129 | Congenital, generalized hypertrichosis (HP:0004540) | 2.00020964 |
| 130 | Autoimmune hemolytic anemia (HP:0001890) | 1.99943333 |
| 131 | Lactic acidosis (HP:0003128) | 1.99735353 |
| 132 | Pili torti (HP:0003777) | 1.99538026 |
| 133 | Increased IgE level (HP:0003212) | 1.98418751 |
| 134 | Concave nail (HP:0001598) | 1.98225577 |
| 135 | Medulloblastoma (HP:0002885) | 1.97834781 |
| 136 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.97799159 |
| 137 | Facial diplegia (HP:0001349) | 1.96898840 |
| 138 | Fatigable weakness (HP:0003473) | 1.96579792 |
| 139 | Abnormality of the neuromuscular junction (HP:0003398) | 1.96579792 |
| 140 | Natal tooth (HP:0000695) | 1.96263887 |
| 141 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.96094223 |
| 142 | Hepatocellular necrosis (HP:0001404) | 1.96014468 |
| 143 | Hypoplasia of the radius (HP:0002984) | 1.95109706 |
| 144 | Protrusio acetabuli (HP:0003179) | 1.94633417 |
| 145 | Beaking of vertebral bodies (HP:0004568) | 1.94284370 |
| 146 | Tongue fasciculations (HP:0001308) | 1.93758015 |
| 147 | Esophageal atresia (HP:0002032) | 1.93668896 |
| 148 | Systemic lupus erythematosus (HP:0002725) | 1.93129006 |
| 149 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.91996014 |
| 150 | Breech presentation (HP:0001623) | 1.91629197 |
| 151 | Diaphragmatic weakness (HP:0009113) | 1.90044236 |
| 152 | Recurrent abscess formation (HP:0002722) | 1.89965986 |
| 153 | Hypoplastic left heart (HP:0004383) | 1.89861109 |
| 154 | Vertebral compression fractures (HP:0002953) | 1.88575961 |
| 155 | Myelodysplasia (HP:0002863) | 1.88437239 |
| 156 | Personality changes (HP:0000751) | 1.87890504 |
| 157 | Hepatic necrosis (HP:0002605) | 1.87726880 |
| 158 | Hyperammonemia (HP:0001987) | 1.86563711 |
| 159 | IgM deficiency (HP:0002850) | 1.86032470 |
| 160 | Lymphopenia (HP:0001888) | 1.85605519 |
| 161 | 3-Methylglutaconic aciduria (HP:0003535) | 1.84777777 |
| 162 | Gonadal dysgenesis (HP:0000133) | 1.84436696 |
| 163 | Nail dystrophy (HP:0008404) | 1.84118402 |
| 164 | Dicarboxylic aciduria (HP:0003215) | 1.83060192 |
| 165 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.83060192 |
| 166 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.83035539 |
| 167 | CNS hypomyelination (HP:0003429) | 1.81441270 |
| 168 | Stridor (HP:0010307) | 1.81403252 |
| 169 | Oligodactyly (HP:0012165) | 1.80728208 |
| 170 | Increased CSF lactate (HP:0002490) | 1.78985157 |
| 171 | Rectal fistula (HP:0100590) | 1.78611500 |
| 172 | Rectovaginal fistula (HP:0000143) | 1.78611500 |
| 173 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78491715 |
| 174 | Abnormality of abdominal situs (HP:0011620) | 1.78069264 |
| 175 | Abdominal situs inversus (HP:0003363) | 1.78069264 |
| 176 | Chromsome breakage (HP:0040012) | 1.77580763 |
| 177 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.76378995 |
| 178 | Metaphyseal cupping (HP:0003021) | 1.76091638 |
| 179 | Areflexia of lower limbs (HP:0002522) | 1.75987092 |
| 180 | Aplastic anemia (HP:0001915) | 1.75672364 |
| 181 | Facial cleft (HP:0002006) | 1.74957464 |
| 182 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.74701648 |
| 183 | Duodenal stenosis (HP:0100867) | 1.73968192 |
| 184 | Small intestinal stenosis (HP:0012848) | 1.73968192 |
| 185 | Prominent nose (HP:0000448) | 1.72669846 |
| 186 | Patent foramen ovale (HP:0001655) | 1.72596671 |
| 187 | Recurrent fungal infections (HP:0002841) | 1.71351944 |
| 188 | Increased muscle lipid content (HP:0009058) | 1.71149985 |
| 189 | CNS demyelination (HP:0007305) | 1.70320477 |
| 190 | Biconcave vertebral bodies (HP:0004586) | 1.68256285 |
| 191 | Spondylolisthesis (HP:0003302) | 1.68231688 |
| 192 | Abnormality of B cell number (HP:0010975) | 1.67184117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.22895367 |
| 2 | WEE1 | 4.29784491 |
| 3 | VRK2 | 3.64115949 |
| 4 | EPHA2 | 3.09257111 |
| 5 | PBK | 2.83952817 |
| 6 | PLK4 | 2.82410985 |
| 7 | MUSK | 2.77436016 |
| 8 | ERN1 | 2.67829332 |
| 9 | EIF2AK1 | 2.65834480 |
| 10 | NME2 | 2.65390078 |
| 11 | TSSK6 | 2.60200533 |
| 12 | NEK2 | 2.58636985 |
| 13 | NEK1 | 2.49266676 |
| 14 | FES | 2.38832330 |
| 15 | TNK2 | 2.33086840 |
| 16 | TTK | 2.32400030 |
| 17 | MAP3K13 | 2.31166672 |
| 18 | RPS6KB2 | 2.11087940 |
| 19 | MAP3K12 | 2.06505347 |
| 20 | TESK1 | 2.06198740 |
| 21 | CDC7 | 2.02068593 |
| 22 | RPS6KA4 | 1.99465206 |
| 23 | LATS2 | 1.94074914 |
| 24 | PLK1 | 1.93514056 |
| 25 | MYLK | 1.81332352 |
| 26 | TESK2 | 1.80606795 |
| 27 | CDK7 | 1.74259272 |
| 28 | TAOK3 | 1.70946245 |
| 29 | TBK1 | 1.66955969 |
| 30 | CDK12 | 1.65640450 |
| 31 | SRPK1 | 1.62925004 |
| 32 | STK10 | 1.59345638 |
| 33 | DYRK3 | 1.57600941 |
| 34 | ACVR1B | 1.52328353 |
| 35 | PLK3 | 1.51240163 |
| 36 | CHEK2 | 1.47003495 |
| 37 | LMTK2 | 1.45938976 |
| 38 | ZAK | 1.45188839 |
| 39 | AKT3 | 1.40658332 |
| 40 | CSF1R | 1.40633816 |
| 41 | STK16 | 1.35847567 |
| 42 | TGFBR2 | 1.35009082 |
| 43 | STK38L | 1.34822853 |
| 44 | AURKB | 1.32959489 |
| 45 | ILK | 1.32443714 |
| 46 | MAP3K8 | 1.31810299 |
| 47 | CDK4 | 1.30945262 |
| 48 | TRIB3 | 1.30628743 |
| 49 | MAP3K14 | 1.30255282 |
| 50 | KDR | 1.29969032 |
| 51 | BRSK2 | 1.27833396 |
| 52 | MAPKAPK3 | 1.24754829 |
| 53 | LIMK1 | 1.23040804 |
| 54 | EIF2AK3 | 1.22983785 |
| 55 | CCNB1 | 1.22599743 |
| 56 | MAP3K11 | 1.22535896 |
| 57 | AURKA | 1.22534779 |
| 58 | ALK | 1.20458406 |
| 59 | PNCK | 1.20407254 |
| 60 | PAK4 | 1.16075561 |
| 61 | PIM1 | 1.10985465 |
| 62 | CDK8 | 1.10403929 |
| 63 | DAPK1 | 1.08607021 |
| 64 | PIM2 | 1.04194130 |
| 65 | ABL2 | 1.03269261 |
| 66 | PRKCI | 1.02518955 |
| 67 | MAP3K3 | 0.97373298 |
| 68 | MKNK2 | 0.96254446 |
| 69 | ATR | 0.95354805 |
| 70 | MAP4K2 | 0.93340765 |
| 71 | CHEK1 | 0.90322713 |
| 72 | MKNK1 | 0.87631747 |
| 73 | BMX | 0.85151375 |
| 74 | VRK1 | 0.84628364 |
| 75 | PAK1 | 0.84065088 |
| 76 | HCK | 0.83408545 |
| 77 | PRKCQ | 0.83299004 |
| 78 | PRKD3 | 0.83110923 |
| 79 | CSK | 0.82251126 |
| 80 | FGR | 0.81444294 |
| 81 | PTK2B | 0.81262877 |
| 82 | CDK9 | 0.79135721 |
| 83 | KIT | 0.79030626 |
| 84 | JAK1 | 0.77524656 |
| 85 | PDK2 | 0.76054825 |
| 86 | MST4 | 0.76046222 |
| 87 | SIK3 | 0.75182997 |
| 88 | DAPK3 | 0.74122662 |
| 89 | BRSK1 | 0.73987295 |
| 90 | LATS1 | 0.73499867 |
| 91 | IKBKE | 0.70037237 |
| 92 | MAP2K3 | 0.69799392 |
| 93 | BMPR1B | 0.69707332 |
| 94 | BLK | 0.69165402 |
| 95 | CDK2 | 0.68566932 |
| 96 | NME1 | 0.68332795 |
| 97 | MOS | 0.68303910 |
| 98 | JAK3 | 0.67878264 |
| 99 | MTOR | 0.67832451 |
| 100 | ERBB4 | 0.66814858 |
| 101 | CDK6 | 0.66246064 |
| 102 | TGFBR1 | 0.66188102 |
| 103 | PDK1 | 0.65368719 |
| 104 | TRIM28 | 0.65132182 |
| 105 | DDR2 | 0.63425211 |
| 106 | NEK6 | 0.62555070 |
| 107 | IRAK3 | 0.62064185 |
| 108 | LRRK2 | 0.61340229 |
| 109 | STK3 | 0.60892157 |
| 110 | MAP3K5 | 0.59737442 |
| 111 | BCKDK | 0.59181088 |
| 112 | MELK | 0.59110527 |
| 113 | CSNK2A2 | 0.58369995 |
| 114 | MAP4K1 | 0.58354502 |
| 115 | PASK | 0.58330738 |
| 116 | LYN | 0.57232902 |
| 117 | TAOK2 | 0.57184196 |
| 118 | RIPK1 | 0.57058254 |
| 119 | EEF2K | 0.56643148 |
| 120 | CSNK2A1 | 0.56623884 |
| 121 | PKN2 | 0.54660838 |
| 122 | PINK1 | 0.53815949 |
| 123 | BRAF | 0.53775953 |
| 124 | ROCK1 | 0.53612883 |
| 125 | SYK | 0.52221696 |
| 126 | IKBKB | 0.51146564 |
| 127 | ATM | 0.50202095 |
| 128 | PDK4 | 0.49806518 |
| 129 | PDK3 | 0.49806518 |
| 130 | PIK3CG | 0.49213390 |
| 131 | ARAF | 0.48290099 |
| 132 | GRK1 | 0.47908630 |
| 133 | ERBB3 | 0.47282676 |
| 134 | MAPKAPK2 | 0.46959186 |
| 135 | TYK2 | 0.46828993 |
| 136 | ZAP70 | 0.46640755 |
| 137 | LCK | 0.43226036 |
| 138 | PRKG2 | 0.42886836 |
| 139 | NLK | 0.42817062 |
| 140 | CSNK1E | 0.42711384 |
| 141 | TIE1 | 0.42630544 |
| 142 | TAOK1 | 0.42079335 |
| 143 | DYRK2 | 0.41715388 |
| 144 | MAPK4 | 0.41224502 |
| 145 | PAK2 | 0.40454818 |
| 146 | DYRK1B | 0.40445785 |
| 147 | CDK1 | 0.40383528 |
| 148 | FGFR4 | 0.40321873 |
| 149 | TLK1 | 0.38966508 |
| 150 | PDPK1 | 0.38146702 |
| 151 | ABL1 | 0.37853410 |
| 152 | GRK6 | 0.37601483 |
| 153 | TAF1 | 0.36264769 |
| 154 | EIF2AK2 | 0.35857877 |
| 155 | AKT2 | 0.35338258 |
| 156 | SMG1 | 0.35179550 |
| 157 | MAP2K2 | 0.35152228 |
| 158 | CHUK | 0.34884287 |
| 159 | ROCK2 | 0.34833922 |
| 160 | BTK | 0.34511343 |
| 161 | INSR | 0.34341691 |
| 162 | PRKD2 | 0.34218752 |
| 163 | RAF1 | 0.33954735 |
| 164 | FGFR1 | 0.33231179 |
| 165 | RPS6KA5 | 0.33168352 |
| 166 | STK4 | 0.32175031 |
| 167 | TYRO3 | 0.30313231 |
| 168 | MARK3 | 0.26433263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.78192853 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.28209420 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 4.25807682 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.84604710 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.84364292 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 3.59725843 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 3.35988992 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 3.30143328 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 3.29800460 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.88154498 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.66956889 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.60180470 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.42184811 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.42089204 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.40535596 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.33546970 |
| 17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.32307028 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.28512680 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.18496433 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 2.12655017 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.09652252 |
| 22 | p53 signaling pathway_Homo sapiens_hsa04115 | 2.09138654 |
| 23 | Asthma_Homo sapiens_hsa05310 | 2.03228735 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.98430416 |
| 25 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.95104317 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85656156 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.77739368 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.76016075 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.74887158 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.73053173 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.69384556 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.55769364 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51373380 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.51246538 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49834359 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.43928696 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.43499502 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42649536 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.37036612 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.35723073 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.34213691 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.27861517 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 1.24277268 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21669589 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.21484205 |
| 46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.20336293 |
| 47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19665042 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.19550320 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10317476 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.10309751 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.08955359 |
| 52 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.08769891 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07714821 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.03988193 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02116058 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.01461460 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99077661 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98972870 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93794211 |
| 60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.91484129 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84969569 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84293510 |
| 63 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84220415 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83936527 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82564610 |
| 66 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.82450516 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82446126 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81674239 |
| 69 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.80034315 |
| 70 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79855135 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78372571 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77391073 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77363914 |
| 74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.71938831 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71459021 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71153041 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68208944 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66656511 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66243138 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65001162 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64060656 |
| 82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64026127 |
| 83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.63876329 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63764505 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62501763 |
| 86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.60922522 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59484828 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58947476 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.58776053 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57452841 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.57425294 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57217356 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56042987 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55601181 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55527507 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.55061415 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53535283 |
| 98 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.52997476 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52727924 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51761546 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51590967 |
| 102 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.50866407 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49984916 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49867099 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49689564 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49613140 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.49528790 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49358104 |
| 109 | Measles_Homo sapiens_hsa05162 | 0.48000878 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46339674 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.45603669 |
| 112 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45168228 |
| 113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45100152 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45038373 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44949695 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44815479 |
| 117 | Phototransduction_Homo sapiens_hsa04744 | 0.44253677 |
| 118 | Allograft rejection_Homo sapiens_hsa05330 | 0.44034311 |
| 119 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43719979 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.43375132 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.42824557 |
| 122 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42211663 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41454712 |
| 124 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41094373 |
| 125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41074763 |
| 126 | Legionellosis_Homo sapiens_hsa05134 | 0.41043261 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.40913282 |
| 128 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.40425153 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40137134 |
| 130 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39359685 |
| 131 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38830405 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38501632 |
| 133 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35377269 |
| 134 | Tight junction_Homo sapiens_hsa04530 | 0.35307856 |
| 135 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34490118 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.33370994 |
| 137 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32397546 |
| 138 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32105602 |
| 139 | Pathways in cancer_Homo sapiens_hsa05200 | 0.30687900 |
| 140 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.29816090 |
| 141 | Pertussis_Homo sapiens_hsa05133 | 0.29505667 |
| 142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28057654 |
| 143 | Bladder cancer_Homo sapiens_hsa05219 | 0.27828572 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27546213 |
| 145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.23166693 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.19556557 |
| 147 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.19490093 |
| 148 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.18406616 |
| 149 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.18290315 |
| 150 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.17990629 |
| 151 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.17952640 |
| 152 | Hepatitis B_Homo sapiens_hsa05161 | 0.16670265 |
| 153 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.15788560 |
| 154 | Prostate cancer_Homo sapiens_hsa05215 | 0.15611653 |
| 155 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15493690 |
| 156 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15080644 |

